Table 2.
Neurocognitive and Quality of Life (QoL) Assessment Compliance
| Assessment | Treatment Arm | Evaluation Status | Baseline | At 6 months | At 12 months |
|---|---|---|---|---|---|
| HVLT | 2.5 Gy × 10 | Expected | 131 | 123 | 104 |
| Dead / alive and not evaluated | 0 / 12 | 8 / 57 | 19 / 59 | ||
| Received (%) | 119 (91%) | 66 (54%) | 45 (43%) | ||
| 2.0 Gy × 18 | Expected | 67 | 58 | 49 | |
| Dead / alive and not evaluated | 0 / 5 | 9 / 24 | 9 / 29 | ||
| Received (%) | 62 (93%) | 34 (59%) | 20 (41%) | ||
| 1.5 Gy × 24 | Expected | 66 | 63 | 57 | |
| Dead / alive and not evaluated | 0 / 5 | 3 / 27 | 6 / 38 | ||
| Received (%) | 61 (92%) | 36 (57%) | 19 (19%) | ||
| TMT A | 2.5 Gy × 10 | Expected | 131 | 123 | 104 |
| Dead / alive and not evaluated | 0 / 12 | 8 / 58 | 19 / 60 | ||
| Received (%) | 119 (91%) | 65 (53%) | 44 (42%) | ||
| 2.0 Gy × 18 | Expected | 67 | 58 | 49 | |
| Dead / alive and not evaluated | 0 / 5 | 9 / 24 | 9 / 29 | ||
| Received (%) | 62 (93%) | 34 (59%) | 20 (41%) | ||
| 1.5 Gy × 24 | Expected | 66 | 63 | 57 | |
| Dead / alive and not evaluated | 0 / 6 | 3 / 27 | 6 / 39 | ||
| Received (%) | 60 (91%) | 36 (57%) | 18 (32%) | ||
| TMT B | 2.5 Gy × 10 | Expected | 131 | 123 | 104 |
| Dead / alive and not evaluated | 0 / 17 | 8 / 60 | 19 / 61 | ||
| Received (%) | 114 (87%) | 63 (51%) | 43 (41%) | ||
| 2.0 Gy × 18 | Expected | 67 | 58 | 49 | |
| Dead / alive and not evaluated | 0 / 5 | 9 / 24 | 9 / 29 | ||
| Received (%) | 62 (93%) | 34 (59%) | 20 (41%) | ||
| 1.5 Gy × 24 | Expected | 66 | 63 | 57 | |
| Dead / alive and not evaluated | 0 / 7 | 3 / 27 | 6 / 39 | ||
| Received (%) | 59 (89%) | 36 (57%) | 18 (32%) | ||
| COWAT | 2.5 Gy × 10 | Expected | 131 | 123 | 104 |
| Dead / alive and not evaluated | 0 / 13 | 8 / 57 | 19 / 60 | ||
| Received (%) Expected | 118 (90%) | 66 (54%) | 44 (42%) | ||
| 2.0 Gy × 18 | Expected | 67 | 58 | 49 | |
| Dead / alive and not evaluated | 0 / 5 | 9 / 24 | 9 / 29 | ||
| Received (%) | 62 (93%) | 34 (59%) | 20 (41%) | ||
| 1.5 Gy × 24 | Expected | 66 | 63 | 57 | |
| Dead / alive and not evaluated | 0 / 5 | 3 / 27 | 6 / 38 | ||
| Received (%) | 61 (92%) | 36 (57%) | 19 (33%) | ||
|
QoL Measures + |
2.5 Gy × 10 | Expected | 131 | 122 | 94 |
| Dead / alive and not evaluated | 0 / 11 | 9 / 51 | 28 / 47 | ||
| Received (%) | 120 (92%) | 71 (58%) | 47 (50%) | ||
| 2.0 Gy × 18 | Expected | 67 | 58 | 47 | |
| Dead / alive and not evaluated | 0 / 5 | 9 / 18 | 11 / 25 | ||
| Received (%) | 62 (93%) | 40 (69%) | 22 (47%) | ||
| 1.5 Gy × 24 | Expected | 66 | 63 | 52 | |
| Dead / alive and not evaluated | 0 / 5 | 3 / 26 | 11 / 29 | ||
| Received (%) | 61 (92%) | 37 (59%) | 23 (44%) | ||
HVLT = Hopkins Verbal Learning Test
TMT = Trail Making Test
COWAT = Controlled Oral Word Association Test
QoL Measures = Quality of Life Questionnaire (QLQ-C30) and Brain Cancer Module 20 (BN 20)